In medical terms, an agonist is a manufactured substance that attaches to a cell receptor and causes the same action as the naturally occurring substance
Meta-analyses of randomized clinical trials (RCTs) on GLP-1RA type drugs show an overall 37% increased risk of gallbladder or biliary diseases (1,5,6)
That reveals four very different outcomes, from categories under sustained pressure, to those whose decline is only temporary, to those set for sustained growth
Factors such as genetics, lifestyle, and adherence to the medication regimen can impact weight loss outcomes
Additionally, GLP-1 supports heart health by lowering blood pressure and cholesterol, improves insulin sensitivity, and may enhance mood and mental clarity by stabilizing metabolic fluctuations
In fact, its FDA-approved under the brand name Zepbound for chronic weight management. #PharmD #DrugUpdate #Mounjaro #Tirzepatide #ClinicalPharmacy #PharmacyPractice #DiabetesCare #Pharmacology #HealthcareInnovation #PatientCounseling To view or add a comment, sign in Dapagliflozin Dapagliflozin is an oral anti-diabetic medication belonging to the class SGLT2 inhibitors (Sodium-Glucose Co-Transporter 2 inhibitors)